A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 Oct 2017
At a glance
- Drugs AAV-hAADC (Primary)
- Indications Inborn error amino acid metabolic disorders
- Focus Therapeutic Use
- 18 Oct 2017 Planned End Date changed from 1 Sep 2016 to 31 Dec 2020.
- 18 Oct 2017 Planned primary completion date changed from 1 Oct 2015 to 31 Dec 2020.
- 18 Oct 2017 Status changed from completed to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History